Skip to content
Stop using now Drug recall · FDA · Published April 17, 2025

Amneal Ropivacaine Injection Recall: Particulate Matter Hazard

Amneal Pharmaceuticals recalls 0.5% Ropivacaine Hydrochloride Injection due to particulate matter risk. Affected lots expire 01/31/2026. Contact for return instructions.

🇺🇸 FDA recall #D-0402-2025DrugAmneal ›
Take action

Contact the company

Recalling firmAmneal Pharmaceuticals, LLC400 Crossing Blvd Fl 3 · Bridgewater, NJ 08807-2863
✎ GovInfoNow plain-language explainer

Amneal Pharmaceuticals is recalling certain ropivacaine injections because they may contain particles that could cause serious injury if injected. This recall affects specific lots manufactured in India and distributed in the US. Read more at govinfonow.com/recall/32132-amneal-ropivacaine-injection-recall-particulate-matter-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/32132-amneal-ropivacaine-injection-recall-particulate-matter-hazard · Updated August 18, 2026 · FDA enforcement record: FDA #D-0402-2025

Cite this page

“Amneal Ropivacaine Injection Recall: Particulate Matter Hazard.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32132-amneal-ropivacaine-injection-recall-particulate-matter-hazard. Based on FDA recall #D-0402-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0402-2025%22&limit=1).

The FDA announced on April 17, 2025, that Amneal Pharmaceuticals voluntarily recalled Ropivacaine Hydrochloride Injection due to the presence of particulate matter. The Class I recall affects lots AL240003 and AL240004 with expiration dates of January 31, 2026.

How to tell if you have it

  • Brand: Amneal
  • Product: Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL)
  • NDC: 70121-1734-1 (bag); 70121-1734-3 (box)
  • Lot codes: AL240003, AL240004
  • Expiration: 01/31/2026

The hazard

The recall is due to the presence of particulate matter in the injection. The FDA classified this as a Class I recall, indicating a high risk of serious adverse health consequences or death.

Context

GovInfoNow's records show Amneal Pharmaceuticals has 9 other recalls on record since December 12, 2016. Other recent recalls include an Amneal Estradiol Gel recall for defective packets (September 8, 2026), an Amneal Primidone Tablets recall for cross-contamination risk (June 3, 2026), and an Amneal traMADol 50mg Tablets recall for NDSRI impurity risk (March 19, 2026). Other recent recalls of similar products include GE Healthcare Omnipaque Injection and Omnipaque 300 mg/mL Injection recalls for particulate matter hazard (March 24, 2026) and an American Regent Papaverine HCl Injection recall for particulate matter hazard (July 24, 2026).

How to tell if you have this one

Check the NDC numbers: 70121-1734-1 (bag) or 70121-1734-3 (box). The product was manufactured in India with lot numbers AL240003 or AL240004 and expires January 31, 2026.

  • Brand
    Amneal
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled ropivacaine injection if you have it. Do not administer or inject the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 18 months after the firm started it.

1. Firm started the recall: Apr 17, 202512. FDA classified it Class I: May 5, 202523. Published in FDA’s Enforcement Report: May 14, 202534. FDA terminated the recall: Oct 5, 2026420252026
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Amneal recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0402-2025 (April 17, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0402-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA